PINNBROOK CAPITAL MANAGEMENT LP

Position in NTRA — Natera, Inc.

CIK 1856103 NEW YORK, NY

Back to NTRA Full portfolio

Position in NTRA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$18,811,485

+$9,216,738 QoQ

Shares Held

69,300

+65.5% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

3.13%

of 13F equity value

Holder Rank

#157

of 844 holders

Holding Since

Jun 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTRA Over Time

Shares Held

Position Value (USD)

Derivatives in NTRA

reported options exposure · as of Mar 31, 2025

CallValue

$21,918,550

CallShares

155,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

PINNBROOK CAPITAL MANAGEMENT LP holds $27,154,336 across 4 Diagnostics & Research names. NTRA ranks #1 (69.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTRA	Natera, Inc. This page	69,300	$18,811,485
2	CRL	Charles River Laboratories International, Inc.	21,300	$4,830,627
3	WAT	Waters Corp /De/	5,360	$2,010,214
4	RVTY	Revvity, Inc.	13,500	$1,502,010

All Filings in NTRA

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,811,485	69,300	+65.5%	Shares	Sole	2026-08-12
2025-12-31	$9,594,747	41,882	+16.6%	Shares	Sole	2026-02-06
2025-09-30	$5,781,076	35,914	+78.7%	Shares	Sole	2025-11-13
2025-03-31	$2,842,341	20,100	+15.3%	Shares	Sole	2025-05-12
2025-03-31	$21,918,550	155,000	—	Call	Sole	2025-05-12
2024-09-30	$2,213,881	17,439	-35.8%	Shares	Sole	2024-11-13
2024-06-30	$2,943,322	27,180	—	Shares	Sole	2024-08-13
No filing history on record for this holder in this stock.